Navigation Links
Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
Date:10/3/2007

ls, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis Media Relations

Beth Birke

Novartis Vaccines and Diagnostics

Global Communications

+1-617-871-4281

beth.birke@novartis.com

e-mail: media.relations@novartis.com or nvd.communications@novartis.com

Media materials

For images and video related to Novartis Vaccines & Diagnostics please visit http://www.thenewsmarket.com/novartisvaccines. Journalists may register and download print-quality images and broadcast-standard video from this site at no charge.


'/>"/>
SOURCE Novartis Vaccines and Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Novartis files application with FDA for Zometa
2. Canine Painkiller unveiled by Novartis
3. Glivec the hot cancer drug from Novartis
4. Zometa [Novartis Drug] For Treatment Of Paget’s Diseas
5. Novartis MS Drug Shows Promising Results
6. Bird-flu Vaccine Adjuvant Contract Goes to Novartis
7. Drop Patent Petition, Activists Ask Novartis
8. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
9. Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
10. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
11. Novartis Drug Diovan Shows Superior Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ced Acquisition in 2009 Continues Growth Trend , ...rstCall/ -- IPC The Hospitalist Company, Inc. (Nas...ician group practice company, announced today that...st Acute Care Consultants, Inc. (MACC) in St. Loui...expansion in the St. Louis market, where IPC has e...
(Date:1/8/2009)...Jan. 8 The Pew Charitab...een named director, chemical and food safety progr...gram. Olson, who was formerly deputy staff directo...nvironment and Public Works, brings nearly 25 year...er advocacy to Pew. , , "We are excited to be ...
(Date:1/8/2009)... Jan. 8 Cephalon, Inc ....ino, Jr., Ph.D., Chairman and CEO will present at... on January 13, 2009 in San Francisco, CA at appro...me). The presentation will be webcast live on the ...e. , , The webcast will be archived for one we...
(Date:1/8/2009)...lo., Jan. 8 Heska Corpor...bcast: , , , What: Heska Corporation I... Year-End 2008 Earnings Conference Call on t...:00 a.m. (MST], Where: www.heska.com (cli... Call link on the front page of this website)....
Breaking Medicine News(10 mins):Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2
...nvolving more than 65, 000 persons show a positi... the risk of developing cancer//. Dr. Par Stattin...m, who examined data from 31,304 men and 33,293 wo...cts had previously participated in a larger study...
...change in health caused by an unintentional injury... are more likely to have difficulty// obtaining re...ce larger declines in short-term health, according...he Urban Institute, Washington, D.C., presented th...
...le phones when the ban on them gets lifted shortly...s because it was believed// that its electromagnet...al equipments. But as per the directive issued fro...d everywhere excepting near a few specialist equip...
...om the Centers for Disease Control// and Preventio...atistics have decreased significantly in their cou... this mainly to routine hepatitis immunizations, i...reports that more than 100,000 Americans were infe...
Other Medicine News:Health News:Beware of High Sugar Levels Even If You are Not Diabetic 2Health News:Uninsured Often Receive Less Medical Care 2Health News:Hepatitis Rates Plummet in the U.S 2
(Date:1/7/2009)...tan Puhua Hospital Stem Cells Center ( http://www....g stem cells to effectively treat neurological dis...ed additions to its medical and research staff tha...pabilities for growing numbers of incoming interna...e distinguished Dr. Jiang Ping, who was named Chie...
(Date:1/6/2009)...ire/ -- The Michael J. Fox Foundation awarded a to...h teams for pre-clinical research on potential new...nding was awarded under the Foundation,s Therapeu...launched in 2006, supports and bolsters industry-f...art of MJFF,s focus on ,de-risking, preclinical ...
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/29/2008)...SNewswire/ -- The winner of the 2008 Award for Exc... today by Dr. Peter G. Goldschmidt, President and ..., The winner of the annual award was the Unive...or its best practice " IND Regulatory and Monitori...d human subjects protection, 2) improved data qual...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 1Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 2Few Employers Addressing Workplace Stress Watson Wyatt Surveys Find 11948 3Strategy for nanotechnology related environmental health and safety research 2209 1Strategy for nanotechnology related environmental health and safety research 2209 2IAEA helps recover stray radioactive sources in Nigeria 2204 1IAEA helps recover stray radioactive sources in Nigeria 2204 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 1DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 2DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference 11941 3
...r 18, 2007 - Nymox,Pharmaceutical Corporation (NAS...month follow-up study of NX-1207 for benign,prosta...atic,progress of U.S. patients involved in the Com...dividuals in the study were assessed,for symptomat... of,efficacy. Patients in the study were assessed ...
...WIRE)--Apr 17, 2007 -,Seattle Genetics, Inc. (Nasd...tations by the company and its collaborators at th...for Cancer Research,(AACR) demonstrating preclinic...jugate (ADC) technology and cancer product,pipelin...killing drugs.,Seattle Genetics, ADC technology em...
Other Medicine Technology:Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207,for BPH 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4
If you prefer a standard style iridectomy lens, then consider the Volk Iridectomy Lens. Its 8mm imaging bulb delivers the view you're used to but with the added benefit of Volk's exclusive Double Asp
...d Super Macula® 2.2 offers extremely high reso...vea, while achieving an exceptionally wide 78°...or critical evaluation of the optic nerve head and...f the macula and disc. Redesigned to reduce weight...
...Equator is designed for focal laser therapy and mi...ptical design presents a realistic contour of the ...ld view of the entire posterior pole extending to ...ws dynamic movement on the globe, therefore increa...
...0x Imaging Lens is optimized for the visible spect...ns during general diagnosis and slit lamp imaging....posterior pole and a sharper image across the diam...s also ideal for slit lamp photography. For best r...
Medicine Products: